BRIEF-Beijing Leadman Biochemistry receives patent – Reuters

Fresenius vows TO take breather after three deals

FRANKFURT, May 12 The head of German healthcare group Fresenius SE said he would abstain from the takeover market for now, after striking three deals worth billions of euros in total since taking over less than a year ago.

Here is the original post:
BRIEF-Beijing Leadman Biochemistry receives patent - Reuters

Related Posts